VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure
NCT07375212
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Change in Sponsor
Conditions
Heart Failure Congestive
Interventions
DRUG:
Bumetanide, intranasal 4mg
Sponsor
Prisma Health-Upstate